作者
Abdelsalam M Elhenawy, Khaled D Algarni, Marnie Rodger, Jane MacIver, Manjula Maganti, Robert J Cusimano, Terrence M Yau, Diego H Delgado, Heather J Ross, Vivek Rao
发表日期
2011/9
期刊
Journal of Cardiac Surgery
卷号
26
期号
5
页码范围
542-547
出版商
Blackwell Publishing Inc
简介
Introduction: The use of mechanical circulatory support (MCS) in nontransplant eligible candidates remains controversial. Our decision to offer MCS for nontransplant candidates has led to their reevaluation after a period of left ventricular assist device (LVAD) support. Methods: From 2001 to September 2009, we had 37 patients who received an implantable LVAD, 22 (59%) were not deemed to be transplant eligible at the time of LVAD insertion (bridge to candidacy, BTC group). Results: Fifteen (41%) patients were considered transplant eligible (bridge to transplant, BTT group) at the time of device insertion and received a HeartMate XVE (n = 7), HeartMate 2 (n = 7), or a Novacor LVAS (n = 1). In the BTC group, patients received the HeartMate XVE device (n = 11), HeartMate 2 (n = 5), or the Novacor LVAS (n = 6). The primary criterion for transplant ineligibility was refractory pulmonary hypertension (PH …
学术搜索中的文章
AM Elhenawy, KD Algarni, M Rodger, J MacIver… - Journal of Cardiac Surgery, 2011